Phase III Prospective, Randomized, Double-Blind Registra

  • Dudek, Arkadiusz Z (PI)

Project: Research project

Project Details

Description

Phase III Prospective, Randomized, Double-Blind Registration Study of Lucanix TM (belgenpumatucel-L) vs. Best Supportive Care as Frontline, Adjuvant Therapy for Stages III/IV Non-small Cell Lung Cancer
StatusFinished
Effective start/end date4/1/084/30/13

Funding

  • NOVARX

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.